A study using the combination of tumor markers by Holcomb et al. showed that HE4 was more accurate than other tumor markers, such as CA-125, in predicting epithelial ovarian cancer (88,9% sensitivity and 91,8% specificity) [28]. This evidence concerns the gene MUC16 and neoplasm.